Atlas Trials

A Study to Determine the Dose of WIN-1001X by Evaluating Efficacy and Safety in Early Parkinson's Disease Patients

Clinical trial NCT04220762 · UNKNOWN

Trial details

NCT number
NCT04220762
Sponsor
Medi Help Line
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Parkinson Disease
Start date
2020-01-21
Primary completion
2021-06-01
Enrollment
188

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.